Research projects
Universal, cord blood iPSC-derived CAR-NK cells for an “off-the-shelf” immunotherapy for cancer
Principal Investigator
Miquel de Homdedeu
Duration
2025 -2026
Funded by
Fundació Investigació Salut i Progrés (1st Edition of FISP Miquel Rutllant Research Grants)
Objective
To provide experimental proof of concept for a novel off-the-shelf combinatorial immunotherapy that will use immunocompatible induced Pluripotent Stem cells (iPSCs), to develop a next generation of highly efficient, anti-tumor Natural Killer cells.